{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002418","experiment":{"EXPERIMENT_TYPE":"Histone H3K27ac","EXPERIMENT_ID":"EGAX00001379554","attributes":{"CHIP_ANTIBODY":["H3K27ac"],"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["\"4 min; 30 sec ON/ 30 sec OFF\""],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ul"],"CHIP_ANTIBODY_CATALOG":["BP grade"],"EXPERIMENT_TYPE":["Histone H3K27ac"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ug"],"CHIP_ANTIBODY_LOT":["A1723-0041d"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33 ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked 10 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["198"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Pico (UCD-600)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01BTV/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigWig","SIZE":"703M","NAME":"S01BTVH1.ERX1384820.H3K27ac.bwa.GRCh38.20160324.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01BTV/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01BTVH1.ERX1384820.H3K27ac.bwa.GRCh38.20160324.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"9396d2bdc2e2be4ce9859ecd055a5585"},{"FORMAT":"bigBed","SIZE":"3.1M","NAME":"S01BTVH1.ERX1384820.H3K27ac.bwa.GRCh38.20160708.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01BTV/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01BTVH1.ERX1384820.H3K27ac.bwa.GRCh38.20160708.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"aa8fde7f6949174e4ffbdb8b9889dcbb"},{"FORMAT":"BED","SIZE":"3.3M","NAME":"S01BTVH1.ERX1384820.H3K27ac.bwa.GRCh38.20160708.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01BTV/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01BTVH1.ERX1384820.H3K27ac.bwa.GRCh38.20160708.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"1ac52791634ef748af465c408a7076c4"},{"FORMAT":"Text","SIZE":"3.8M","NAME":"S01BTVH1.ERX1384820.H3K27ac.bwa.GRCh38.20160708.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/S01BTV/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01BTVH1.ERX1384820.H3K27ac.bwa.GRCh38.20160708.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"0f037d5709a2eeaaf66ca058481b652f"}],"dataset_id":"EGAD00001002418","sample":{"SAMPLE_SOURCE":"venous blood","SAMPLE_NAME":"S01BTV","sample_barcode":"S01BTVH1","attributes":{"MARKERS":["CD34"],"DONOR_HEALTH_STATUS":["Acute Myeloid Leukemia"],"DONOR_AGE":["55 - 60"],"MOLECULE":["genomic DNA"],"DISEASE":["Acute Myeloid Leukemia"],"BIOMATERIAL_PROVIDER":["Prof.dr. E. Vellenga, University Medical Centre Groningen - Department of Hematology"],"CELL_TYPE":["myeloid cell"],"BIOMATERIAL_TYPE":["Primary Cell"],"TISSUE_TYPE":["venous blood"],"DISEASE_ONTOLOGY_URI":[{"url":"7","label":"C0023467"}],"SAMPLE_ONTOLOGY_URI":[{"url":"3","label":"CL_0000763"}],"GENDER":["female"],"DONOR_ID":["S01BTV"],"DONOR_SEX":["Female"],"DONOR_ETHNICITY":["Caucasian"]},"SAMPLE_ID":"EGAN00001374925","SAMPLE_DESCRIPTION":"Acute Myeloid Leukemia"}}